Refine by
Oncological Treatment Suppliers & Manufacturers
25 companies found
based inXiamen, CHINA
Amoy Diagnostics Co., Ltd. (AmoyDx) is an R&D based diagnostic company, focusing on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS®, Super-ARMS®, ddCapture® and ADx-HANDLE® ...
Lung cancer is one of the most common malignant tumor, and 80~85% of lung cancers are non-small cell lung cancer (NSCLC). There are many driver mutations in NSCLC. The frequency of mutations in patients with NSCLC for the EGFR gene is 10~35%, for ...
based inGarching / Munich, GERMANY
ITM Isotope Technologies Munich SE is a privately owned biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes ...
based inMilano, ITALY
BetaGlue Technologies can deliver a localized amount of energy via a simple, intra-operative, internal radiotherapy platform engineered to achieve maximum efficacy and much improved safety for the patients. A new anti-tumoral compound based on 90Y ...
The Betaglue team has identified an area of unmet need and has developed a novel solution for the prevention of the complications occurring during percutaneous biopsy procedures in soft tissues, such as hemorrhage, pneumothorax (PNX) or tumor ...
based inBrignais, FRANCE
Appolon Bioteck is a French research-focused healthcare company with combined strengths in Medical genetic diagnostics, oncology, virology and inflammation. We provide diagnostic tools that enable tangible improvements in the health, quality of life ...
Companion diagnostics is becoming a key element in cancer treatment. New predictive biomarkers and molecular strategies for personalized cancer therapies are currently available to treat each individual patient depending on the genetic ...
based inMalmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
based inCambridge, UNITED KINGDOM
Biosceptre is a biopharmaceutical company focused on chimeric antigen receptor (CAR) T-cell therapy and immune-oncology treatment, that’s committed to bringing a new range of targeted therapies to a wide range of cancer patients. With Nobel ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
based inMöhrendorf, GERMANY
QRM has a legacy spanning over 25 years in the design and manufacturing of phantoms for diverse medical imaging modalities. Initially focusing on lung imaging in CT and bone densitometry in DXA and CT, the company has since broadened its catalog to ...
The Comprehensive Electron Density Phantom is designed for calibrating the Hounsfield Unit (HU) relative to electron density in CT radiotherapy treatment plans, ensuring optimal dosage for patients. This advanced phantom includes a water-equivalent ...
based inAustin, TEXAS (USA)
Natera is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health and inform earlier, more ...
Support treatment decisions with comprehensive tumor profiling. Gain deep insight into the tumor’s genomic alterations and oncology biomarkers with Altera. The detailed sequencing report includes ...
based inJeddah, SAUDI ARABIA
Gulf Medical Company was founded in 1983 as a medical supply company specialized in the sales and marketing of medical devices and equipment, with the sole proprietorship of the vision “To bring the most innovative state of the art medical ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
Iadademstat (ORY-1001) dihydrochloride is a selective irreversible lysine (K)-specific demethylase 1A (KDM1A/LSD1) ...
based inSeoul, SOUTH KOREA
GI Innovation is a bio-venture company that researches and develops innovative protein new drugs through well-structured translational research. The primary research and development for GI Innovation is immuno-oncology drug and allergy disease and ...
based inPalo Alto, CALIFORNIA (USA)
Varian Medical Systems, Inc., headquartered globally in Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and ...
Fast, precise planning for advanced cancer care. The Eclipse treatment planning system has been developed and advanced with the collaboration of clinicians to be better able to treat their patients. Thousands of hospitals and cancer treatment ...
based inKloten, SWITZERLAND
Arcomed is one of the most respected infusion technology providers in the world. The company has a long history and was officially founded in 1974. Since then, arcomed ag has focused on the domain of infusion technology, offering a full range of ...
Arcomed’s PP line concept offers a Polypropelene-based solution for consumables which avoids many environmental issues such as toxic waste through the incineration process. It is also the least susceptible plastic to mismedication due to ...
based inHamburg, GERMANY
Indivumed GmbH was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy. As a physician-led, integrated global oncology company our experts leverage the world’s premier multi-omics ...
Cancer immunology, or “immuno-oncology,” is a growing field of research that aims to discover innovative cancer immunotherapies to treat and impede the progression of the disease. Understanding how cancer evades the immune system is ...
based inDurham, NORTH CAROLINA (USA)
Cancer is the second leading cause of death in the U.S. and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the most effective ...
based inMorrisville, NORTH CAROLINA (USA)
NantHealth empowers the creation of integrated healthcare delivery networks. In developing technology that supports systems and data, we enable efficiency, personalized treatment, and collaboration across health care. NantHealth is recognized by ...
Payers, seeking a clearer view into treatment validity, turn to Eviti Connect. Focused on high-quality, high-value care, the platform offers insight payers need to make reimbursement decisions. For payers, Eviti Connect streamlines the ...
based inColumbus, OHIO (USA)
Deep Lens is a digital healthcare company focused on a groundbreaking approach to faster recruitment of the best-suited cancer patients to clinical trials. VIPER, Deep Lens’ integrated cloud platform, provides care teams with visibility and ...
VIPER is a unique patient recruitment tool specifically designed to inform and educate care teams of potential trial participants earlier than alternative methods through optimizing their enrollment process and not allowing patients to slip through ...
based inHeywood, UNITED KINGDOM
Envair Technology, rooted in the containment industry and formed by merging the expertise of Envair and TCS, provides innovative clean air technologies. The company offers a comprehensive range of products, including rigid isolators, microbiological ...
based inSantiago de Compostela, SPAIN
We are a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer. Our patented MPN Technology enables the discovery and development of new compounds involving intracellular ...